MedPath

The effect of nigella sativa powder on appetite and appetite hormone in patients with helicobacter pylori

Phase 4
Conditions
helicobacter pylori infection.
Disease of stomach and duodenum, unspecified
Registration Number
IRCT20170916036204N7
Lead Sponsor
Shiraz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
60
Inclusion Criteria

positive result of helicobacter pylori infection

Exclusion Criteria

Body mass index greater than 30
Having an inflammatory or chronic diseases (kidney disease, liver disease, inflammatory bowel disease, heart ischemia, diabetes, lung disease, asthma, cancer, HIV, systemic inflammation and…)
Having history of gastric cancer or gastric surgery
Active GI bleeding and intense gastritis
Taking any antibiotics or bismuth from 6 weeks before the study
Taking all types of medication for helicobacter pylori before the study
Pregnancy or lactation at the same time as studying
Drinking alcohol or using narcotic at the same time as studying

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Ghrelin hormone. Timepoint: at the beginning and the end of the study (after 8 weeks ). Method of measurement: ghrelin kit.
Secondary Outcome Measures
NameTimeMethod
Appetite. Timepoint: at the beginning and the end of the study. Method of measurement: appetite questionnaire.
© Copyright 2025. All Rights Reserved by MedPath